Last 47 quarters of trend data · Healthcare · Drug Manufacturers - Specialty & Generic
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -4.96 | — | — | 0.20 | — | — | — | — | — | — | — | — | 1.04 | — | 0.08 | 0.71 | 0.46 | 0.36 | 0.55 | 0.28 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | +126.1% | — | -85.1% | +149.5% | — | -36.7% | — | — | — | |
| P/S Ratio | 1.28 | 3.09 | 1.07 | 0.05 | 0.53 | 0.06 | 0.06 | 0.10 | 0.09 | 0.07 | 0.08 | 0.15 | 0.23 | 0.19 | 0.14 | 0.10 | 0.10 | 0.09 | 0.07 | 0.04 | 0.07 |
| — | +4966.1% | +1562.9% | -50.8% | +455.1% | -13.2% | -15.8% | -34.4% | -59.1% | -63.3% | -46.4% | +54.2% | +132.1% | +111.2% | +92.9% | +136.6% | +45.4% | -7.1% | +120.2% | -30.5% | -33.1% | |
| P/B Ratio | 1.60 | 1.62 | 0.62 | 0.09 | 0.66 | 0.06 | 0.07 | 0.09 | 0.09 | 0.07 | 0.07 | 0.11 | 0.15 | 0.13 | 0.13 | 0.10 | 0.11 | 0.12 | 0.10 | 0.04 | 0.08 |
| — | +2626.2% | +801.7% | +2.8% | +638.2% | -12.2% | -6.4% | -20.5% | -40.2% | -47.7% | -42.6% | +12.3% | +36.7% | +9.5% | +32.3% | +128.1% | +44.7% | +19.1% | +24.4% | -59.9% | -24.2% | |
| P/FCF | — | 3.58 | — | — | 0.81 | — | 0.18 | — | 0.40 | 0.30 | 0.43 | 2.03 | 0.52 | 0.36 | 0.27 | 0.32 | 0.24 | 0.12 | 0.61 | 0.22 | 1.81 |
| — | — | — | — | +101.7% | — | -58.1% | — | -23.6% | -15.1% | +57.6% | +525.5% | +115.0% | +196.3% | -55.0% | +47.2% | -86.6% | — | — | — | — | |
| EV / EBITDA | 14.21 | — | — | 0.15 | 11.02 | — | — | 0.89 | 0.62 | -5.88 | — | — | 0.10 | 0.06 | 0.41 | 0.29 | 0.32 | 0.34 | 0.80 | 0.51 | — |
| — | — | — | -83.5% | +1665.5% | — | — | — | +522.9% | -10536.6% | — | — | -68.6% | -83.2% | -49.1% | -42.0% | — | -50.0% | — | — | — | |
| EV / EBIT | — | — | — | 0.22 | — | — | — | — | — | — | — | — | 0.12 | 0.05 | 0.34 | 0.41 | 0.60 | 0.48 | 0.60 | 1.05 | 4.41 |
| — | — | — | — | — | — | — | — | — | — | — | — | -80.3% | -90.5% | -42.5% | -60.7% | -86.4% | -83.1% | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.9% | 13.9% | 32.8% | 61.0% | 31.7% | 35.6% | 63.9% | 74.1% | 71.4% | 65.6% | 70.5% | 80.2% | 88.4% | 87.1% | 88.1% | 88.3% | 87.1% | 89.6% | 85.3% | 88.0% | 85.7% |
| — | -60.9% | -48.7% | -17.7% | -55.6% | -45.7% | -9.4% | -7.5% | -19.1% | -24.8% | -19.9% | -9.2% | +1.4% | -2.8% | +3.2% | +0.3% | +1.6% | +4.2% | +3.3% | +8.3% | +14.9% | |
| Operating Margin | -14.5% | -185.9% | -67.6% | 26.1% | -27.5% | -48.9% | -41.9% | -10.4% | -11.6% | -13.4% | -98.0% | -640.7% | 30.3% | 10.9% | 21.1% | 18.8% | 30.7% | 31.6% | 23.9% | 23.3% | -47.3% |
| — | -280.5% | -61.4% | +349.9% | -136.6% | -265.6% | +57.3% | +98.4% | -138.4% | -222.2% | -564.6% | -3507.0% | -1.4% | -65.4% | -11.9% | -19.3% | +164.9% | +13.1% | +123.1% | +220.6% | +62.1% | |
| Net Margin | -25.6% | -189.8% | -88.1% | 23.1% | -56.0% | -51.1% | -32.6% | -10.0% | -11.8% | -13.9% | -174.0% | -784.6% | 20.7% | -8.2% | 175.9% | 12.2% | 22.3% | 24.8% | 13.8% | 14.7% | -55.8% |
| — | -271.3% | -170.6% | +331.4% | -374.1% | -267.8% | +81.3% | +98.7% | -157.1% | -69.4% | -198.9% | -6531.3% | -7.3% | -133.1% | +1172.6% | -16.8% | +139.9% | +46.5% | +118.1% | +148.2% | +66.6% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -28.3% | -22.2% | -11.9% | 11.5% | -16.2% | -11.8% | -8.3% | -2.2% | -2.8% | -3.3% | -34.7% | -125.0% | 3.4% | -1.5% | 49.1% | 3.2% | 6.5% | 8.5% | 4.6% | 4.0% | -14.3% |
| — | -88.5% | -43.4% | +616.9% | -488.0% | -256.3% | +76.0% | +98.2% | -182.1% | -126.3% | -170.6% | -4043.5% | -48.6% | -117.3% | +962.3% | -19.8% | +145.5% | +49.7% | +112.5% | +130.2% | +64.9% | |
| ROA | -11.0% | -7.9% | -4.1% | 3.9% | -5.8% | -4.7% | -3.7% | -1.1% | -1.3% | -1.6% | -17.2% | -71.2% | 2.1% | -0.8% | 24.0% | 1.3% | 2.4% | 2.7% | 1.5% | 1.2% | -4.4% |
| — | -66.3% | -8.8% | +466.6% | -346.0% | -198.8% | +78.3% | +98.5% | -163.3% | -88.6% | -171.7% | -5604.2% | -12.8% | -130.9% | +1532.1% | +5.8% | +153.3% | +88.4% | +119.2% | +139.4% | +63.6% | |
| ROIC | -11.0% | -13.5% | -5.9% | 10.0% | -6.0% | -8.6% | -8.3% | -1.8% | -2.4% | -3.3% | -18.5% | -89.8% | 4.2% | 1.6% | 4.3% | 3.5% | 6.1% | 6.5% | 4.6% | 3.7% | -7.1% |
| — | -55.6% | +28.6% | +670.0% | -146.1% | -162.7% | +55.1% | +98.0% | -158.5% | -311.8% | -526.4% | -2682.6% | -31.6% | -76.1% | -5.2% | -6.2% | +186.3% | +48.4% | +123.7% | +196.3% | +69.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.43 | 0.53 | 0.43 | 0.38 | 0.43 | 0.37 | 0.33 | 0.30 | 0.31 | 0.29 | 0.29 | 0.22 | 0.16 | 0.15 | 0.30 | 0.51 | 0.49 | 0.67 | 0.74 | 0.84 | 0.90 |
| — | +43.6% | +28.1% | +24.0% | +38.9% | +25.9% | +15.7% | +41.4% | +96.8% | +91.4% | -3.0% | -57.9% | -67.9% | -77.1% | -60.0% | -39.4% | -45.7% | -20.3% | -54.1% | -29.9% | -25.6% | |
| Debt / EBITDA | 3.13 | — | — | 2.15 | 32.34 | — | — | 10.84 | 13.14 | 29.19 | — | — | 2.10 | 3.47 | 3.52 | 4.74 | 3.29 | 3.72 | 4.94 | 6.12 | — |
| — | — | — | -80.1% | +146.1% | — | — | — | +525.0% | +740.9% | — | — | -36.0% | -6.6% | -28.7% | -22.6% | — | -40.2% | — | — | — | |
| Current Ratio | 1.70 | 1.82 | 1.70 | 1.58 | 1.59 | 1.66 | 1.77 | 2.01 | 1.93 | 1.87 | 1.83 | 1.68 | 1.68 | 1.46 | 1.39 | 1.37 | 1.00 | 0.90 | 0.77 | 1.12 | 1.02 |
| — | +9.9% | -3.8% | -21.4% | -17.8% | -11.2% | -3.5% | +19.4% | +14.8% | +28.0% | +31.9% | +22.8% | +67.3% | +61.4% | +81.0% | +22.4% | -1.6% | -20.6% | +7.9% | +40.8% | +1.3% | |
| Quick Ratio | 1.51 | 1.57 | 1.51 | 1.43 | 1.34 | 1.35 | 1.43 | 1.57 | 1.51 | 1.45 | 1.43 | 1.29 | 1.44 | 1.29 | 1.24 | 1.22 | 0.90 | 0.83 | 0.71 | 1.07 | 0.96 |
| — | +16.2% | +5.4% | -8.7% | -11.1% | -6.7% | +0.3% | +21.2% | +4.3% | +12.6% | +14.7% | +6.5% | +60.6% | +54.1% | +74.9% | +14.1% | -6.8% | -20.9% | +14.3% | +53.8% | +17.7% | |
| Interest Coverage | -8.74 | -23.27 | -14.22 | 15.80 | -20.22 | -16.38 | -11.53 | -3.43 | -3.65 | -4.78 | -8.07 | -1.65 | 21.39 | 12.31 | 17.12 | 5.05 | 4.46 | 6.12 | 8.43 | 2.58 | 0.77 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ASRT stock.
Assertio Holdings, Inc.'s current P/E is -5.0x. The average P/E over the last 1 quarters is 0.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Assertio Holdings, Inc.'s current operating margin is -14.5%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Assertio Holdings, Inc.'s business trajectory between earnings reports.